Botulinum toxin injection pain relief using a topical anesthetic skin refrigerant

J Plast Reconstr Aesthet Surg. 2010 Sep;63(9):1443-6. doi: 10.1016/j.bjps.2009.07.045. Epub 2009 Aug 27.

Abstract

Background: This study was performed to determine if pretreatment application of a topical anesthetic skin refrigerant reduced discomfort during botulinum toxin injection.

Methods: Twenty patients were assigned to four groups determined by side of the face pretreated with skin refrigerant and side receiving the first injection. On a Visual Analog Scale of 0-10 patients rated discomfort levels after injections in the glabellar complex with and without pretreatment.

Results: Mean discomfort rating for the pretreated side was 3.1, while the mean discomfort rating for the non-pretreated side was 4.5. Discomfort was not affected by the side sprayed (p=0.33) nor by administering the injection to the sprayed side first (p=0.37). The paired t-test revealed a significant difference between discomfort levels on the pretreated and non-pretreated sides (p=0.038) yielding a 95% confidence interval of (-2.71, -0.09).

Conclusions: Topical anesthetic skin refrigerant significantly reduces discomfort in a cost-effective manner for reported by patients undergoing botulinum injections.

Publication types

  • Comparative Study
  • Randomized Controlled Trial

MeSH terms

  • Administration, Topical
  • Aerosols
  • Anesthetics, Local / administration & dosage
  • Anesthetics, Local / therapeutic use*
  • Botulinum Toxins, Type A / administration & dosage*
  • Botulinum Toxins, Type A / adverse effects*
  • Drug Combinations
  • Facial Pain / drug therapy*
  • Facial Pain / etiology
  • Female
  • Fluorocarbons
  • Humans
  • Hydrocarbons, Fluorinated / administration & dosage
  • Hydrocarbons, Fluorinated / therapeutic use*
  • Injections / adverse effects*
  • Male
  • Middle Aged
  • Neuromuscular Agents / administration & dosage*
  • Neuromuscular Agents / adverse effects*
  • Pain Measurement
  • Regression Analysis
  • Treatment Outcome

Substances

  • Aerosols
  • Anesthetics, Local
  • Botulinum Toxins, Type A
  • Drug Combinations
  • Hydrocarbons, Fluorinated
  • Neuromuscular Agents
  • pain ease refrigerant
  • pentafluoropropane-tetrafluoroethane
  • Fluorocarbons